TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ELDN

Eledon Pharmaceuticals Inc

Healthcare · Biotechnology

2.60$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Eledon Pharmaceuticals Inc (ELDN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 169 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ELDN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
108 68 30 21 17 11 197 171 93 126 177 169
108 67 30 19 14 10.0 116 88 60 56 144 136
105 24 23 17 13 8.8 114 85 56 4.6 21 23
105 64 27 17 13 8.8 114 85 56 51 140 133
0.6 0.2 0.1 0.5
0.9 1.3
0.0 0.0 0.0 0.3 0.1 0.8
1.9 1.9 0.0 49 49 0.0
32 32 32 32 32 32
4.2 6.3 2.9 1.4 2.5 1.5 6.6 6.6 8.6 42 59 88
4.2 6.2 2.8 1.4 2.5 1.3 2.5 4.4 6.5 3.9 12 18
3.4 0.2 0.1 0.4 0.4 0.4 0.3 0.4
0.8 1.2 0.3 0.4 0.7 0.3 1.4 1.8 2.2 1.0 5.8 3.6
104 62 27 19 14 9.5 191 164 84 83 118 81
-86 -131 -169 -28 -42 -58 -80 -115 -203 -243 -356 -401
0.7 2.5 4.2 4.7 9.0 12 15 15 14 25 49 82

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?